Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 10/31/23
End: 12/30/25
Due: 12/30/26
Phase: N/A
Priority: Normal
Start: 06/03/17
End: 12/31/19
Due: 12/31/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification | NCT03958591 | Yanbing Li | user2@example.com | None | 2019-05-01 | 2022-12-31 | 2023-12-31 | - | - | 2025-07-14 |
| Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes | NCT06007014 | Yanbing Li | user2@example.com | None | 2023-10-31 | 2025-12-30 | 2026-12-30 | - | - | 2025-07-14 |
| A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy | NCT03320031 | Yanbing Li | user2@example.com | None | 2017-06-03 | 2019-12-31 | 2020-12-31 | - | - | 2025-07-14 |